Products

What will AGI do for Alipamide?

This classification denotes a diuretic with the molecular formula C9H12ClN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PE8925K9EY, chemically known as 4-chloro-3-sulfamoylbenzoic acid 2,2-dimethylhydrazide but generally known as alipamide, which bears US NIH Compound Identifier 18520. European Medicines Agency schedules Alipamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05331MIG. The term ALIPAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). ALIPAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alipamide under HS 29350090 and SITC 51580. As of Q4 2014, ALIPAMIDE remains the US FDA Preferred Term for this commodity. Alipamide bears US NLM identifiers UMLS ID C2825440 and NCI Concept Code C81071. SMILES: CLC1C(S(=O)(=O)N)CC(CC1)C(=O)NN(C)C.

How AGI delivers it

Four ways AGI delivers for Alipamide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alipamide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alipamide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alipamide connects

measured by

  • Assay Puritymodel
  • Moisture Contentmodel
  • Particle Size Distributionmodel
  • Residual Solventmodel